🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

ANI Pharmaceuticals, Inc.

ANIP Healthcare
$71.47 +$1.48 (2.11%)
Market Cap: $1.51 B
Gurus Holding
4
Popularity Rank
#2467
% of Shares Held
1.22%
Net Activity (Q3 2026)
+$1.1 M

Guru Ownership Trend

Guru Analysis for ANI Pharmaceuticals, Inc. (ANIP)

ANI Pharmaceuticals, Inc. (ANIP), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $18.53 M.

Top institutional holders include HOTCHKIS & WILEY and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $1.1 M net inflow during the quarter.

Recent activity highlights HOTCHKIS & WILEY who increased their stake by 141.7%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 71.7%.

Key Holders

Recent Activity Breakdown (Q3 2026)

+$8.88 M
Total Buy Value
New Buys 0
Additions 2
-$7.78 M
Total Sell Value
Reductions 2
Sold Out 3

Guru Consensus (Q3 2026)

Based on recent activity
Net Sellers
5
Net Buyers
2

FAQs for ANI Pharmaceuticals, Inc. (ANIP)

Major holders include HOTCHKIS & WILEY ($14.82 M), Cliff Asness ($2.08 M), Renaissance Technologies (RenTech) ($1.31 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 259,330 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $1.1 M, with 2 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 2 managers trimmed their positions, while 3 fully exited ANIP. The total reported sell value was $7.78 M.

Yes, 0 managers opened new positions in ANIP, and 2 increased their existing holdings. The total reported buy value was $8.88 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.04% Add 141.7% 204,017 $14.82 M Q3 2026
0.00% Reduce -2.9% 28,642 $2.08 M Q3 2026
0.00% Reduce -71.7% 18,000 $1.31 M Q3 2026
0.00% Add 43.9% 8,671 $629,948 Q3 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form